(For treatment side effects and complications only)
Albumin Paclitaxel (Abraxane) Protocol V1.1
EC-D Epirubicin, Cyclophosphamide followed by Docetaxel Adjuvant Neo-adjuvant Breast Cancer V1.1
EC-DH Epirubicin, Cyclophosphamide followed by Docetaxel with Trastuzumab Protocol V1.1
EC-D with HP Epirubicin, Cyclophosphamide follwed by Docetaxel, Trastuzumab, Pertuzumab Neo-Adjuvant & Adjuvant Protocol V2.1
EC (Epirubicin Cyclophosphamide) Adjuvant Neo-adjuvant regimen V1.1
Paclitaxel Albumin (Abraxane) Breast Cancer V1.1
Paclitaxel/Carboplatin with Dose Dense EC Neoadjuvant Regimen Protocol V1.1
Paclitaxel Weekly Neoadjuvant Breast Cancer V1.0
Paclitaxel with Dose Dense EC Neoadjuvant Adjuvant Breast Cancer V1.1
Paclitaxel with EC Adjuvant or Neoadjuvant Protocol V1.1
Pembrolizumab with Carboplatin/Paclitaxel and EC Neoadjuvant Breast Cancer Regimen followed by Adjuvant Pembrolizumab V1.0
TCHP-Docetaxel, Carboplatin, Trastuzumab, Pertuzumab Neoadjuvant & Adjuvant Protocol V2.2